Mary Ann Liebert, Inc.

The current pandemic has touched everyone a little differently. In this podcast we hear the perspectives of a urologist working at ground zero during the New York City crisis and how he and his department managed during these challenging times.

In this podcast our expert faculty Patty Telgener, VP of Reimbursement of Emerson Consultants and Claudia Graham, former Senior VP of Global Access of Dexcom discuss tips on CGM coding. Topics discussed include an overview of coding for professional CGM (codes 95250 and 95251), personal CGM (code 95249), and how the COVID-19 pandemic has impacted CGM coding.

In this podcast our expert faculty Dr. Gregory Forlenza of The Barbara Davis Center discusses the use and benefits of automated insulin delivery in children and adults. Topics discussed include commercially available automated insulin delivery systems in the U.S. and globally, systems currently in development, the role of interoperability, including integrated continuous glucose monitoring (iCGM).

In this episode, Jennifer Harbottle, Senior R&D Scientist with Horizon, discusses Horizon’s research and resources in the field of base editing.

In this episode, Steve Smith, Product Manager with Horizon Discovery, reviews the latest tools in the CRISPR toolbox for gene modulation, activation and suppression

In this episode, Horizon’s Screening Business Unit Manager, Nicola McCarthy, shares some best practices when it comes to running CRISPR screens in primary cells.

This episode brings together three leading experts in PCNL to discuss various aspects of Prone and Supine PCNL which will enhance your practice. The discussion encompasses key point of surgical technique with focus on equipment such as Pulse laser modulation technique, positioning patients and miniaturization of the PCNL tract.

In this podcast Dr. Dirk Lange will discuss some of the challenges that are faced in stent design, and what potential solutions may be for these common issues.

In this podcast our expert faculty, Drs. Lori Laffel and Daniel DeSalvo discuss the use and benefits of real-time CGM in young children, adolescents, and young adults. Topics discussed include clinical study outcomes, ways to increase utilization in these age ranges, and benefits of real-time CGM.

In this episode, Ciaran Lee shares some insights on the choice of repair pathways in editing experiments and strategies to increase HDR in primary stem cells and other contexts.

In this episode, Samira Kiani discusses genetic means of regulating CRISPR to ensure safety and clinical applications in immunomodulation.

In this episode of the podcast series, Dr. Jodi Antonelli will share her approaches to commonly encountered issues in the management of metabolic stone disease. These insights will highlight ways in which patients with both simple as well as more complex metabolic stone disease may be managed.

In this episode, Mandana Arbab, a postdoc in David Liu’s lab, discusses editing outcomes using CRISPR-Cas9 and base editing and the development of the respective online resources, inDelphi and BE-Hive.

This episode delves into the problems associated with ureteral stents. We tackle practical tips for placement in challenging circumstances, address patient quality of life after stent placement, and discuss the future of stents.

Podcast Summary: In this conversation with Dr. Brian Matlaga, Dr. Brian Eisner shares what inspired him to develop supine PCNL as a part of his practice. He will review how he learned to perform supine PCNL, his present treatment protocols, as well as advanced techniques.

In this podcast Dr. Viral Shah and Dr. Janet McGill discuss the use of RT-CGM in the senior population. Topics discussed include benefits of RT-CGM, addressing barriers and improving utilization in seniors using technology, and clinical study outcomes.

In this episode, Ryan Donnelly (Horizon Discovery) discusses a user-friendly guide to streamlining CRISPR knockout workflows in cell lines including guide design, delivery and strategy, as well as tips for avoiding common pitfalls.

In this podcast we will be discussing the benefits and value of professional CGM. We will be reviewing the differences between professional and personal CGM, blinded and unblinded use cases, as well as the basics of CGM data interpretation and reimbursement. We will highlight Dexcom G6 Professional System and discuss candidates for personal vs. professional CGM.

Podcast Summary: In this conversation with Dr. Brian Matlaga, Dr. Michael Lipkin will provide his insights into the considerations of fluid management during stone treatment and also review platforms available to address this consideration.

In this episode Dr. Amy Krambeck and Dr. Brian Matlaga discuss how and why to implement HoLEP into your surgical practice.

This episode explores the latest advances in laser technology for the treatment of kidney stones in granular detail, broaching such topics as pulse modulation, laser techniques, and efficiency. Expert opinion and advice from three leading experts will help enhance your practice.

In this episode Dr. Bodo Knudsen discusses the emerging role of mini-PCNL in stone management, and how it can be implemented into your practice.

In this episode Dr. Craig G. Rogers discusses Partial Nephrectomy as a standard treatment option that can be performed even for challenging tumors. Various tools and approaches are available to help achieve tumor control while preserving kidney function and minimizing complications. Robotic assistance may facilitate a minimally-invasive approach for complex partial nephrectomy cases. Important sur...

In this episode Dr. Ojas Shah of Columbia University Vagelos College of Physicians and Surgeons discusses the challenging nature of the management of ureteral strictures and how patient selection is critical in determining success rates when treating with an endourologic approach. This podcast covers etiologies of ureteral strictures, characteristics that will help predict success rates of differe...

Jason Sheltzer (Cold Spring Harbor Laboratory) discusses challenges and best practices to generating gene knockouts in cell lines using CRISPR-Cas9, as well as his group’s tour de force application of the technology to reveal stunning discrepancies between drugs that are in clinical trials and their supposed mechanism of action.